BusinessAxsome Therapeutics Reports First Quarter 2018 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 8, 2018, 11:01 AM UTC
BusinessAxsome Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018By Nasdaq OMXMay 1, 2018, 11:01 AM UTC
BusinessAxsome Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMar 7, 2018, 12:01 PM UTC
BusinessAxsome Therapeutics to Present at 2018 BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 5, 2018, 12:00 PM UTC
BusinessAxsome Therapeutics Announces AXS-02 Independent Data Monitoring Committee Recommends Continuation of COAST-1 Trial and Discontinuation of CREATE-1 TrialBy Nasdaq OMXJan 9, 2018, 12:02 PM UTC
BusinessAxsome Therapeutics to Present at Biotech Showcase 2018By Nasdaq OMXDec 19, 2017, 12:01 PM UTC
BusinessAxsome Therapeutics Announces AXS-07 for the Treatment of MigraineBy Nasdaq OMXNov 28, 2017, 12:00 PM UTC
